Company / Current Liabilities per Share
OptimizeRx Corp Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.15
FY2025
5-year range
$0.47 / $1.15
FY2021-FY2025
Trend
+5.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has increased for 3 consecutive years, from $0.47 in FY2022 to $1.15 in FY2025.
Based on SEC 10-K filings.
1.15 in FY2025 with a 5-year CAGR of +10.9%.
Increased from $1.01 to $1.15 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +34.8%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 5.8% year-over-year.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +5.8% |
| FY2024 | $1.09 | +8.3% |
| FY2023 | $1.01 | +113.9% |
| FY2022 | $0.47 | -28.6% |
| FY2021 | $0.66 | -4.0% |
| FY2020 | $0.69 | +35.3% |
| FY2019 | $0.51 | +17.2% |
| FY2018 | $0.43 | +263.1% |
| FY2017 | $0.12 | -5.6% |
| FY2016 | $0.13 | -14.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026